Concept:
The management of gout is strictly divided into two phases: terminating the acute inflammatory flare, and long-term urate-lowering therapy (ULT) to prevent future attacks.
During an acute attack, the goal is rapid, potent anti-inflammatory action.
Explanation:
• The primary options for treating an acute gout flare are potent NSAIDs, Colchicine, or Glucocorticoids (oral, intra-articular, or systemic). The choice depends on patient comorbidities.
• NSAIDs (like Indomethacin or Naproxen) are traditionally the first-line therapy for acute gout flares in patients without contraindications (such as peptic ulcer disease, severe chronic kidney disease, or heart failure). Indomethacin is a very potent, fast-acting NSAID historically favored for gout.
• Option (B), Steroids, are highly effective and are the preferred first-line alternative if NSAIDs or colchicine are contraindicated (e.g., in a patient with kidney disease or a bleeding ulcer). However, in general broad guidelines, NSAIDs are cited as the most common initial choice for healthy patients.
• Option (C), Allopurinol, and Option (D), Febuxostat, are Urate-Lowering Therapies (ULTs) functioning as xanthine oxidase inhibitors. They have no anti-inflammatory properties and do absolutely nothing to treat the pain of an acute flare. In fact, initiating them during a flare can cause massive urate shifts and worsen the attack (though modern guidelines state they can be started during an attack if adequate anti-inflammatory coverage is established). They are never the treatment for the acute arthritis itself.
Final answer:
A potent NSAID like Indomethacin is the standard, preferred first-line initial treatment for terminating an acute gouty flare.